Pragnya Donthineni

Dr. Pragnya Donthineni


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
PDPragnya Donthineni
Pragnya Donthineni
SSSwapna Shanbhag
Swapna Shanbhag
Sayan BasuSayan Basu
Sayan Basu
Dry eye disease (DED) is an emerging health concern causing significant visual, psychological, social, and economic impact globally. In contrast to visual rehabilitation undertaken at late stages of DED, measures instituted to prevent its onset, establishment, or progression can alter its natural course and effectively bring down the associated morbidity. This review attempts to present the available literature on preventive strategies of DED at one place, including strategies for risk assessment and mitigation, targeting a wide range of population. A literature search was conducted using PubMed and an extensive literature review on preventive strategies for DED was compiled to put forth a holistic and strategic approach for preventing DED. This can be undertaken at various stages or severity of DED directed at different tiers of the health care system. Conclusion: This review intends to put emphasis on preventive strategies being adopted as an integral part of routine clinical practice by general ophthalmologists and specialists to tackle the burden of DED and improve the quality of the lives of the patients suffering from it.


2 March 2022 in The Ocular Surface
Verified
Journal Article
Open access
SSSwati Singh
Swati Singh
PDPragnya Donthineni
Pragnya Donthineni
SSSwapna Shanbhag
Swapna Shanbhag
SSSirisha Senthil
Sirisha Senthil
HOHon Shing Ong
Hon Shing Ong
Sayan BasuSayan Basu
Sayan Basu
Drug induced cicatrizing conjunctivitis (DICC) is defined as a disease in which conjunctival cicatrization develops as a response to the chronic use of inciting topical and, rarely, systemic medications. DICC accounts for up to one third of cases of pseudopemphigoid, a large group of cicatrizing conjunctival diseases sharing similar clinical features to those of mucous membrane pemphigoid (MMP) but generally without the morbidity of progressive scarring or the need for systemic immunosuppression. The preservatives in topical anti-glaucoma medications (AGM) are the most frequently implicated inciting causes of DICC although topical antivirals, vasoconstrictors and mydriatics and some systemic drugs have been implicated. The literature review summarizes the classification, epidemiology, etiopathogenesis, histopathology, clinical presentation, diagnosis, management, and treatment outcomes of DICC in the context of a case series of 23 patients (42 eyes) with AGM induced DICC, from India and the UK. In this series all subjects reacted to preserved AGM with one exception, who also reacted to non-preserved AGM. At diagnosis >70% of eyes showed punctal scarring, inflammation, and forniceal shortening. Pemphigoid studies were negative in the 19/23 patients in whom they were carried out. DICC can be classified as non-progressive, progressive with positive pemphigoid immunopathology or progressive with negative pemphigoid immunopathology. It is unclear whether progressive DICC is a stand-alone disease, or concurrent (or drug induced) ocular MMP. Progressive cases should currently be treated as ocular MMP. The diagnosis can be made clinically when there is rapid resolution of symptoms and inflammation, usually within 1-16 weeks, after withdrawal of suspected inciting medications, ideally by temporary substitution of oral carbonic anhydrase inhibitors. If the response to withdrawal is uncertain, or the progression of inflammation and scarring continues then patients must be evaluated to exclude concurrent (or drug induced) MMP, and other potential causes of CC, for which the treatment and prognosis is different. Management, in addition to withdrawing inciting medications, may require short-term treatment of conjunctival inflammation with steroids, treatment of associated corneal disease with contact lenses or surface reconstructive surgery, control of intra-ocular pressure with non-preserved AGM and, in some, surgery for glaucoma or for trichiasis and entropion.

5 April 2023 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
AKAnahita Kate
Anahita Kate
RDRashmi Deshmukh
Rashmi Deshmukh
PDPragnya Donthineni
Pragnya Donthineni
NSNamrata Sharma
Namrata Sharma
RVRasik B Vajpayee
Rasik B Vajpayee
Sayan BasuSayan Basu
Sayan Basu
Corneal perforations in eyes with dry eye disease (DED) are difficult to manage due to the interplay of several factors such as the unstable tear film, surface inflammation, and the underlying systemic disease affecting the wound healing process, and the eventual outcome. A careful preoperative examination is required to identify the underlying pathology, and status of ocular surface and adnexa, rule out microbial keratitis, and order appropriate systemic workup in addition to assessing the perforation itself. Several surgical options are available, which include tissue adhesives, multilayered amniotic membrane grafting (AMT), tenon patch graft (TPG), corneal patch graft (CPG), and penetrating keratoplasty (PK). The choice of procedure depends upon the size, location, and configuration of the perforation. In eyes with smaller perforations, tissue adhesives are effective treatment modalities, whereas AMT, TPG, and CPG are viable options in moderate-sized perforations. AMT and TPG are also preferable in cases where the placement of a bandage contact lens may be a challenge. Large perforations require a PK, with additional procedures such as tarsorrhaphy to protect the eyes from the associated epithelial healing issues. Conjunctival flaps are considered in eyes with poor visual potential. The management of the acute condition is carried out in conjunction with measures to improve the tear volume bearing in mind the chances of delayed epithelialization and re-perforation in these cases. Administration of topical and systemic immunosuppression, when indicated, helps improve the outcome. This review aims to facilitate clinicians in instituting a synchronized multifaceted therapy for the successful management of corneal perforations in the setting of DED.

1 June 2021 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SCSimmy Chaudhary
Simmy Chaudhary
SBSayan Basu
Sayan Basu
PDPragnya Donthineni
Pragnya Donthineni
This report describes the long-term outcomes of Tenon's patch graft (TPG) in a corneal perforation secondary to neurotrophic keratitis and outcome of subsequent successful cataract surgery. A 60-year gentleman presented with a corneal perforation secondary to Herpes Zoster ophthalmicus (HZO). After multiple unsuccessful attempts of cyanoacrylate tissue adhesive application over the perforation, he was referred for a corneal patch graft. Following TPG, he had a tectonically stable cornea that was managed with topical steroids and prophylactic oral Acyclovir. Sequential imaging of the cornea using high-resolution anterior segment- optical coherence tomography (HR-ASOCT) was done to monitor wound healing. Fifteen months later, he underwent uneventful cataract surgery with best-corrected visual acuity improving to 20/30 at 1-month. Serial imaging of the site of perforation with HR-ASOCT revealed that a fluffy, oedematous TPG in the early postoperative period transitioned into a hyper-reflective, thin, and compact graft over 3-4 months. Despite the corneal thickness at the site of perforation being only 142 μm, the wound had adequate tensile strength to withstand the altered anterior chamber dynamics during phacoemulsification. The resultant translucent nature of the scar provided superior media clarity and better visual outcomes. This case demonstrates the efficacy of TPG in acute phase management of corneal perforation following HZO thereby restoring the tensile strength of the cornea, enabling it to withstand the stress of future surgeries like phacoemulsification.

21 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
SVShobhit Varma
Shobhit Varma
SSSwapna Shanbhag
Swapna Shanbhag
PDPragnya Donthineni
Pragnya Donthineni
DMDilip Kumar Mishra
Dilip Kumar Mishra
VSVivek Singh
Vivek Singh
Sayan BasuSayan Basu
Sayan Basu
This study aimed to identify the anterior segment high-resolution optical coherence tomography (HR-OCT) and HR-OCT angiography (HR-OCTA) features suggestive of limbal stem cell deficiency (LSCD) as confirmed by both impression cytology (IC) and in vivo confocal microscopy (IVCM). This was a single-centre prospective cross-sectional study including 24 eyes of 22 patients with clinical suspicion of LSCD based on peripheral superficial corneal vascularisation and scarring. On IC and IVCM, performed and interpreted by blinded observers, 12 eyes each were diagnosed with and without LSCD. Additionally, 10 eyes of 5 healthy volunteers with no ocular pathology were also imaged. The 136 HR-OCT/A images of these 34 eyes were analysed with respect to 12 imaging parameters; the parameters most suggestive of LSCD were identified and the sensitivity and specificity were calculated. In the LSCD group, the most common aetiology was ocular chemical burns (83%), whereas in the non-LSCD group, the most common aetiology was viral keratitis (67%). Multiple logistic regression analysis revealed that mean epithelial reflectivity, mean stromal reflectivity, and mean superficial vascular density were the parameters that were diagnostic of LSCD on HR-OCT/A (p < 0.0001). A ratio of the mean epithelial reflectivity to stromal reflectivity of >1.29 corresponded with a high sensitivity (91.7%) and specificity (98.75%); while a mean superficial vascular density score of >0.38 corresponded with a sensitivity of 97.9% and specificity of 73.8%. In conclusion, HR-OCT/A as a non-invasive imaging modality could prove to be a useful tool for confirming the diagnosis of LSCD, with potential clinical and research applications.